Skip to content

Driving Deep Learning and Drug Discovery with and Intel – Intel on AI episode 15

Sumit Sanyal, Founder and Chief Revenue Officer at, joins Intel on AI to discuss the Netrin Molecular Property Predictor (MPP) and how is driving drug discovery with deep learning. He describes how the solution enables pharmaceutical companies to replace traditional labor and time intensive wet lab tests instead using graph convolutional deep neural networks (GCNNs) to make predictions about molecules and target proteins that may be useful in medications. This is revolutionizing the drug discovery industry by accelerating and reducing the cost of molecule testing. Sumit also talks about how has been utilizing the Intel® Math Kernel Library (MKL) and Intel® Xeon Scalable processors to help drive their incredibly fast neural network training. He highlights how using Xeon processors is incredibly efficient in comparison to graphics processing units (GPU) and expresses how helpful the Intel® MKL has been for

Read about this on Intel’s AI Builder’s site.


How can we help?

Reach out – we’d love to hear about how we can help.

We use cookies and similar technologies to enable services and functionality on our site and to understand your interaction with our service. By clicking on accept, you agree to our use of such technologies for analytics. See Privacy Policy

Leave this field blank